Build Your Comparison

Side-by-side financial analysis
UNH logo
UNH
HUM logo
HUM
Try popular comparisons:

Stock Comparison

UNH vs HUM

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals30-year financialsFull price history
UNH
UnitedHealth Group Incorporated

Health Insurers

HealthcareNYSE • US
Market Cap$317.77B
5Y Perf.+4.0%
HUM
Humana Inc.

Health Insurers

HealthcareNYSE • US
Market Cap$46.31B
5Y Perf.-3.7%

UNH vs HUM — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
UNH logoUNH
HUM logoHUM
IndustryHealth InsurersHealth Insurers
Market Cap$317.77B$46.31B
Revenue (TTM)$449.66B$154.19B
Net Income (TTM)$15.88B$1.25B
Gross Margin22.8%13.0%
Operating Margin5.3%1.3%
Forward P/E17.0x42.1x
Total Debt$78.39B$12.94B
Cash & Equiv.$24.36B$4.20B

UNH vs HUM — Long-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

UNH
HUM
StockNov 20Nov 26Return
UnitedHealth Group … (UNH)100104.0+4.0%
Humana Inc. (HUM)10096.3-3.7%

Price return only. Dividends and distributions are not included.

Quick Verdict: UNH vs HUM

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: UNH leads in 6 of 7 categories, making it the strongest pick for growth and revenue expansion and valuation and capital efficiency. Humana Inc. is the stronger pick specifically for recent price momentum and sentiment. As sector peers, any of these can serve as alternatives in the same allocation.
🥇UNH emerged as the overall leader. Track its performance:
UNH
UnitedHealth Group Incorporated
The Insurance Pick

UNH carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.

  • Dividend streak 16 yrs, beta 0.34, yield 2.5%
  • Rev growth 11.8%, EPS growth -14.7%, 3Y rev CAGR 11.4%
  • 173.6% 10Y total return vs HUM's 106.6%
Best for: income & stability and growth exposure
HUM
Humana Inc.
The Insurance Pick

HUM is the clearest fit if your priority is momentum.

  • +66.3% vs UNH's +14.5%
Best for: momentum
See the full category breakdown
CategoryWinnerWhy
GrowthUNH logoUNH11.8% revenue growth vs HUM's 10.1%
ValueUNH logoUNHLower P/E (19.8x vs 49.1x)
Quality / MarginsUNH logoUNHCombined ratio 1.0 vs HUM's 1.0 (lower = better underwriting)
Stability / SafetyUNH logoUNHBeta 0.34 vs HUM's 0.54
DividendsUNH logoUNH2.5% yield, 16-year raise streak, vs HUM's 0.9%
Momentum (1Y)HUM logoHUM+66.3% vs UNH's +14.5%
Efficiency (ROA)UNH logoUNH5.1% ROA vs HUM's 2.3%, ROIC 9.2% vs 4.1%

UNH vs HUM — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

Discover the Biotech & Healthcare Stocks Theme

These companies are key players in the Biotech & Healthcare Stocks ecosystem. See how they stack up against the rest of the sector.

Explore Theme
UNHUnitedHealth Group Incorporated
FY 2025
Unitedhealthcare
94.4%$332.4B
Optumhealth
5.6%$19.8B
HUMHumana Inc.
FY 2025
Insurance Segment
84.7%$124.6B
CenterWell Segment
15.3%$22.5B

UNH vs HUM — Financial Metrics

Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLUNHLAGGINGHUM

Income & Cash Flow (Last 12 Months)

UNH leads this category, winning 5 of 6 comparable metrics.

UNH is the larger business by revenue, generating $449.7B annually — 2.9x HUM's $154.2B. Profitability is closely matched — net margins range from 3.5% (UNH) to 0.8% (HUM). On growth, HUM holds the edge at +26.1% YoY revenue growth, suggesting stronger near-term business momentum.

MetricUNH logoUNHUnitedHealth Grou…HUM logoHUMHumana Inc.
RevenueTrailing 12 months$449.7B$154.2B
EBITDAEarnings before interest/tax$28.2B$2.8B
Net IncomeAfter-tax profit$15.9B$1.2B
Free Cash FlowCash after capex$22.8B$747M
Gross MarginGross profit ÷ Revenue+22.8%+13.0%
Operating MarginEBIT ÷ Revenue+5.3%+1.3%
Net MarginNet income ÷ Revenue+3.5%+0.8%
FCF MarginFCF ÷ Revenue+5.1%+0.5%
Rev. Growth (YoY)Latest quarter vs prior year-0.4%+26.1%
EPS Growth (YoY)Latest quarter vs prior year+76.1%-17.9%
UNH leads this category, winning 5 of 6 comparable metrics.

Valuation Metrics

UNH leads this category, winning 4 of 6 comparable metrics.

At 19.9x trailing earnings, UNH trades at a 47% valuation discount to HUM's 37.7x P/E. On an enterprise value basis, UNH's 13.2x EV/EBITDA is more attractive than HUM's 20.0x.

MetricUNH logoUNHUnitedHealth Grou…HUM logoHUMHumana Inc.
Market CapShares × price$317.8B$46.3B
Enterprise ValueMkt cap + debt − cash$371.8B$55.0B
Trailing P/EPrice ÷ TTM EPS19.87x37.74x
Forward P/EPrice ÷ next-FY EPS est.16.98x42.11x
PEG RatioP/E ÷ EPS growth rate——
EV / EBITDAEnterprise value multiple13.19x20.00x
Price / SalesMarket cap ÷ Revenue0.71x0.30x
Price / BookPrice ÷ Book value/share3.13x2.63x
Price / FCFMarket cap ÷ FCF13.92x61.99x
UNH leads this category, winning 4 of 6 comparable metrics.

Profitability & Efficiency

UNH leads this category, winning 6 of 9 comparable metrics.

UNH delivers a 15.2% return on equity — every $100 of shareholder capital generates $15 in annual profit, vs $7 for HUM. HUM carries lower financial leverage with a 0.73x debt-to-equity ratio, signaling a more conservative balance sheet compared to UNH's 0.77x. On the Piotroski fundamental quality scale (0–9), UNH scores 6/9 vs HUM's 5/9, reflecting solid financial health.

MetricUNH logoUNHUnitedHealth Grou…HUM logoHUMHumana Inc.
ROE (TTM)Return on equity+15.2%+6.7%
ROA (TTM)Return on assets+5.1%+2.3%
ROICReturn on invested capital+9.2%+4.1%
ROCEReturn on capital employed+9.7%+4.0%
Piotroski ScoreFundamental quality 0–965
Debt / EquityFinancial leverage0.77x0.73x
Net DebtTotal debt minus cash$54.0B$8.7B
Cash & Equiv.Liquid assets$24.4B$4.2B
Total DebtShort + long-term debt$78.4B$12.9B
Interest CoverageEBIT ÷ Interest expense6.16x3.29x
UNH leads this category, winning 6 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

HUM leads this category, winning 5 of 6 comparable metrics.

A $10,000 investment in HUM five years ago would be worth $9,033 today (with dividends reinvested), compared to $8,650 for UNH. Over the past 12 months, HUM leads with a +66.3% total return vs UNH's +14.5%. The 3-year compound annual growth rate (CAGR) favors HUM at -7.6% vs UNH's -11.1% — a key indicator of consistent wealth creation.

MetricUNH logoUNHUnitedHealth Grou…HUM logoHUMHumana Inc.
YTD ReturnYear-to-date+6.1%+46.8%
1-Year ReturnPast 12 months+14.5%+66.3%
3-Year ReturnCumulative with dividends-29.8%-21.0%
5-Year ReturnCumulative with dividends-13.5%-9.7%
10-Year ReturnCumulative with dividends+173.6%+106.6%
CAGR (3Y)Annualised 3-year return-11.1%-7.6%
HUM leads this category, winning 5 of 6 comparable metrics.

Risk & Volatility

Evenly matched — UNH and HUM each lead in 1 of 2 comparable metrics.

UNH is the less volatile stock with a 0.34 beta — it tends to amplify market swings less than HUM's 0.54 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. HUM currently trades 83.3% from its 52-week high vs UNH's 75.8% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricUNH logoUNHUnitedHealth Grou…HUM logoHUMHumana Inc.
Beta (5Y)Sensitivity to S&P 5000.34x0.54x
52-Week HighHighest price in past year$461.62$462.87
52-Week LowLowest price in past year$255.97$163.11
% of 52W HighCurrent price vs 52-week peak+75.8%+83.3%
RSI (14)Momentum oscillator 0–10042.957.9
Avg Volume (50D)Average daily shares traded5.7M1.5M
Evenly matched — UNH and HUM each lead in 1 of 2 comparable metrics.

Analyst Outlook

UNH leads this category, winning 2 of 2 comparable metrics.

Wall Street rates UNH as "Buy" and HUM as "Hold". Consensus price targets imply 36.8% upside for UNH (target: $479) vs 22.0% for HUM (target: $470). For income investors, UNH offers the higher dividend yield at 2.49% vs HUM's 0.92%.

MetricUNH logoUNHUnitedHealth Grou…HUM logoHUMHumana Inc.
Analyst RatingConsensus buy/hold/sellBuyHold
Price TargetConsensus 12-month target$478.68$470.42
# AnalystsCovering analysts5244
Dividend YieldAnnual dividend ÷ price+2.5%+0.9%
Dividend StreakConsecutive years of raises160
Dividend / ShareAnnual DPS$8.70$3.56
Buyback YieldShare repurchases ÷ mkt cap+1.7%+0.3%
UNH leads this category, winning 2 of 2 comparable metrics.
Key Takeaway

UNH leads in 4 of 6 categories (Income & Cash Flow, Valuation Metrics). HUM leads in 1 (Total Returns). 1 tied.

Best OverallUnitedHealth Group Incorpor… (UNH)Leads 4 of 6 categories

Custom Comparison: UNH vs HUM

Compare on any lens — Growth, Value, Income, or pick from 130+ individual metrics.

View as:

UNH vs HUM: Frequently Asked Questions

10 questions · data-driven answers · updated daily

01

Is UNH or HUM a better buy right now?

For growth investors, UnitedHealth Group Incorporated (UNH) is the stronger pick with 11.

8% revenue growth year-over-year, versus 10. 1% for Humana Inc. (HUM). UnitedHealth Group Incorporated (UNH) offers the better valuation at 19. 9x trailing P/E (17. 0x forward), making it the more compelling value choice. Analysts rate UnitedHealth Group Incorporated (UNH) a "Buy" — based on 52 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — UNH or HUM?

On trailing P/E, UnitedHealth Group Incorporated (UNH) is the cheapest at 19.

9x versus Humana Inc. at 37. 7x. On forward P/E, UnitedHealth Group Incorporated is actually cheaper at 17. 0x.

03

Which is the better long-term investment — UNH or HUM?

Over the past 5 years, Humana Inc.

(HUM) delivered a total return of -9. 7%, compared to -13. 5% for UnitedHealth Group Incorporated (UNH). Over 10 years, the gap is even starker: UNH returned +173. 6% versus HUM's +106. 6%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — UNH or HUM?

By beta (market sensitivity over 5 years), UnitedHealth Group Incorporated (UNH) is the lower-risk stock at 0.

34β versus Humana Inc. 's 0. 54β — meaning HUM is approximately 60% more volatile than UNH relative to the S&P 500. On balance sheet safety, Humana Inc. (HUM) carries a lower debt/equity ratio of 73% versus 77% for UnitedHealth Group Incorporated — giving it more financial flexibility in a downturn.

05

Which is growing faster — UNH or HUM?

By revenue growth (latest reported year), UnitedHealth Group Incorporated (UNH) is pulling ahead at 11.

8% versus 10. 1% for Humana Inc. (HUM). On earnings-per-share growth, the picture is similar: Humana Inc. grew EPS -1. 4% year-over-year, compared to -14. 7% for UnitedHealth Group Incorporated. Over a 3-year CAGR, HUM leads at 11. 7% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — UNH or HUM?

UnitedHealth Group Incorporated (UNH) is the more profitable company, earning 2.

7% net margin versus 0. 9% for Humana Inc. — meaning it keeps 2. 7% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: UNH leads at 4. 2% versus 1. 1% for HUM. At the gross margin level — before operating expenses — UNH leads at 18. 5%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is UNH or HUM more undervalued right now?

On forward earnings alone, UnitedHealth Group Incorporated (UNH) trades at 17.

0x forward P/E versus 42. 1x for Humana Inc. — 25. 1x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for UNH: 36. 8% to $478. 68.

08

Which pays a better dividend — UNH or HUM?

All stocks in this comparison pay dividends.

UnitedHealth Group Incorporated (UNH) offers the highest yield at 2. 5%, versus 0. 9% for Humana Inc. (HUM).

09

Is UNH or HUM better for a retirement portfolio?

For long-horizon retirement investors, UnitedHealth Group Incorporated (UNH) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.

34), 2. 5% yield, +173. 6% 10Y return). Both have compounded well over 10 years (UNH: +173. 6%, HUM: +106. 6%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between UNH and HUM?

Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Related Comparisons

Other popular comparisons that include one of these companies.

Financial Data & Software Notice: VCP Scanner is an educational financial research database and stock screening software platform. VCP Scanner does not generate, recommend, or package trade decisions, buy/sell signals, or personalized investment advice. Side-by-side metric comparisons analyze public fundamental data for analytical evaluation. See our Terms of Service and Privacy Policy.